-
EUDA Health plans January 2026 launch of upgraded supplement
-
EUDA launches stem cell therapy platform and Shenzhen clinic
-
EUDA integrates QB utility token into healthcare rewards platform
-
EUDA plans to integrate QB utility token into healthcare platform
-
EUDA Health raises $100,000 through convertible warrant agreement
-
EUDA signs letter of intent to acquire stem cell company GO POSB
-
EUDA signs letter of intent to acquire biotech firm Chemokine
-
EUDA Health (EUDA) Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
-
EUDA Health (EUDA) and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

